We are live on ! Find out more
CNAM

Campbell Newman Asset Management Portfolio holdings

AUM $1.35B
1-Year Est. Return 38.87%
This Fund
S&P 500
This Quarter Est. Return
+5.48%
1 Year Est. Return
+38.87%
3 Year Est. Return
+107.92%
5 Year Est. Return
+146.05%
10 Year Est. Return
+543.08%
AUM
$1.03B
AUM Growth
+$24.4M
Cap. Flow
-$16.6M
Cap. Flow %
-1.61%
Top 10 Hldgs %
42.29%
Holding
118
New
3
Increased
46
Reduced
38
Closed
7

Top Sells

Rank Stock Value
1
RF icon
Regions Financial
RF
+$14.2M
2
AAPL icon
Apple
AAPL
+$13.1M
3
MSFT icon
Microsoft
MSFT
+$7.97M
4
CCI icon
Crown Castle
CCI
+$6.81M
5
AVGO icon
Broadcom
AVGO
+$2.99M

Sector Composition

Rank Sector Weight
1 Technology 36.64%
2 Healthcare 15.75%
3 Financials 12.32%
4 Industrials 11.43%
5 Consumer Discretionary 7.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TJX icon
76
TJX Companies
TJX
$172B
$1.28M 0.12%
16,345
-4
-0% -$315
PRFT
77
DELISTED
Perficient Inc
PRFT
$1.25M 0.12%
17,338
+216
+1% +$15.8K
META icon
78
Meta Platforms (Facebook)
META
$1.53T
$1.22M 0.12%
5,750
-2
-0% -$341
PLUS icon
79
ePlus
PLUS
$2.32B
$1.18M 0.11%
24,037
+221
+0.9% +$11.2K
BCO icon
80
Brink's
BCO
$4.7B
$1.17M 0.11%
17,557
+227
+1% +$14.4K
OLLI icon
81
Ollie's Bargain Outlet
OLLI
$4.77B
$1.11M 0.11%
19,144
+180
+0.9% +$9.9K
EVR icon
82
Evercore
EVR
$11.6B
$1.1M 0.11%
9,495
+88
+0.9% +$10.9K
PLNT icon
83
Planet Fitness
PLNT
$3.65B
$1.09M 0.11%
14,041
+133
+1% +$10.6K
CORT icon
84
Corcept Therapeutics
CORT
$12.2B
$1.05M 0.1%
48,645
+459
+1% +$10.1K
SYNH
85
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$1.03M 0.1%
28,959
+372
+1% +$13.5K
CEVA icon
86
CEVA Inc
CEVA
$861M
$1.01M 0.1%
33,327
+423
+1% +$13.2K
VRNT
87
DELISTED
Verint Systems
VRNT
$974K 0.09%
26,151
+244
+0.9% +$9.1K
SUPN icon
88
Supernus Pharmaceuticals
SUPN
$2.8B
$917K 0.09%
25,315
+226
+0.9% +$8.69K
BLKB icon
89
Blackbaud
BLKB
$2.07B
$906K 0.09%
13,076
+119
+0.9% +$7.13K
IWR icon
90
iShares Russell Mid-Cap ETF
IWR
$57.7B
$898K 0.09%
12,840
AMD icon
91
Advanced Micro Devices
AMD
$772B
$894K 0.09%
9,117
PFE icon
92
Pfizer
PFE
$152B
$872K 0.08%
21,371
-21,340
-50% -$922K
NVDA icon
93
NVIDIA
NVDA
$5.27T
$834K 0.08%
30,040
IART icon
94
Integra LifeSciences
IART
$1.36B
$816K 0.08%
14,215
+127
+0.9% +$7.16K
TMUS icon
95
T-Mobile US
TMUS
$192B
$784K 0.08%
5,413
+1,758
+48% +$255K
LAD icon
96
Lithia Motors
LAD
$8.4B
$724K 0.07%
3,164
+31
+1% +$7.54K
LULU icon
97
lululemon athletica
LULU
$14.3B
$646K 0.06%
1,775
XOM icon
98
ExxonMobil
XOM
$657B
$645K 0.06%
5,883
PG icon
99
Procter & Gamble
PG
$337B
$617K 0.06%
4,150
MC icon
100
Moelis & Co
MC
$4.93B
$601K 0.06%
15,628
+155
+1% +$6.66K

Similar funds

Campbell Newman Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, Campbell Newman Asset Management held 118 positions worth $1.03B, up 2.4% from $1B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Campbell Newman Asset Management's Q1 2023 filing shows 3 new, 46 increased, 38 reduced and 7 closed positions. Its largest new stake was Arthur J. Gallagher & Co: 85,127 shares worth $16.3M. The largest sale was Regions Financial, an estimated $14.2M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.

  • Campbell Newman Asset Management's largest Q1 2023 buy was Arthur J. Gallagher & Co: 85,127 shares worth $16.3M.
  • Campbell Newman Asset Management added most to Air Products & Chemicals in Q1 2023, an estimated $8.04M increase.
  • Campbell Newman Asset Management's biggest Q1 2023 reduction was Apple, cutting an estimated $13.1M.
  • Campbell Newman Asset Management fully exited Regions Financial in Q1 2023, selling an estimated $14.2M.
  • Campbell Newman Asset Management's ten largest holdings make up 42% of its $1.03B portfolio in Q1 2023.
  • Campbell Newman Asset Management opened 3 new positions and closed 7 in Q1 2023.
  • Campbell Newman Asset Management's portfolio value rose 2.4% quarter-over-quarter to $1.03B.

Based on Campbell Newman Asset Management's 13F filing for Q1 2023, filed 28 Apr 2023.